Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.
Also called NCT01341717
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 440 participants
- Sponsor
- Jothydev's Diabetes and Research Centre
- Registry
-
NCT01341717
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT01341717. Randomized; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2014-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Sitagliptin
- Intervention (Drug)
- Glimepiride
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Insulin
- Lead sponsor
- Jothydev's Diabetes and Research Centre
Record details
- Record id
cardio:ct-nct01341717- Content hash
5a0ef8977f52e19947c5617d275603c9b886718780e00125810e3a5c1c79fd1f